These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24308588)

  • 1. An index of daily step count and systemic inflammation predicts clinical outcomes in chronic obstructive pulmonary disease.
    Moy ML; Teylan M; Danilack VA; Gagnon DR; Garshick E
    Ann Am Thorac Soc; 2014 Feb; 11(2):149-57. PubMed ID: 24308588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily step count is associated with plasma C-reactive protein and IL-6 in a US cohort with COPD.
    Moy ML; Teylan M; Weston NA; Gagnon DR; Danilack VA; Garshick E
    Chest; 2014 Mar; 145(3):542-550. PubMed ID: 24091482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daily step count predicts acute exacerbations in a US cohort with COPD.
    Moy ML; Teylan M; Weston NA; Gagnon DR; Garshick E
    PLoS One; 2013; 8(4):e60400. PubMed ID: 23593211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six-minute-walk distance and accelerometry predict outcomes in chronic obstructive pulmonary disease independent of Global Initiative for Chronic Obstructive Lung Disease 2011 Group.
    Durheim MT; Smith PJ; Babyak MA; Mabe SK; Martinu T; Welty-Wolf KE; Emery CF; Palmer SM; Blumenthal JA
    Ann Am Thorac Soc; 2015 Mar; 12(3):349-56. PubMed ID: 25568929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reasons persons with COPD do not walk and relationship with daily step count.
    Danilack VA; Weston NA; Richardson CR; Mori DL; Moy ML
    COPD; 2014 Jun; 11(3):290-9. PubMed ID: 24152213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Systemic inflammation among stable ex smokers with chronic obstructive pulmonary disease].
    Morales S A; Dreyse D J; Díaz P O; Saldías P F; Carrasco M; Lisboa B C
    Rev Med Chil; 2010 Aug; 138(8):957-64. PubMed ID: 21140052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory changes, recovery and recurrence at COPD exacerbation.
    Perera WR; Hurst JR; Wilkinson TM; Sapsford RJ; Müllerova H; Donaldson GC; Wedzicha JA
    Eur Respir J; 2007 Mar; 29(3):527-34. PubMed ID: 17107990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Directly measured physical activity as a predictor of hospitalizations in patients with chronic obstructive pulmonary disease.
    Zanoria SJ; ZuWallack R
    Chron Respir Dis; 2013; 10(4):207-13. PubMed ID: 24177682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study.
    Kunisaki KM; Rice KL; Janoff EN; Rector TS; Niewoehner DE
    Ther Adv Respir Dis; 2008 Apr; 2(2):55-64. PubMed ID: 19124359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients.
    Gatta D; Aliprandi G; Pini L; Zanardini A; Fredi M; Tantucci C
    Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1068-73. PubMed ID: 22013730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease.
    Sin DD; Lacy P; York E; Man SF
    Am J Respir Crit Care Med; 2004 Oct; 170(7):760-5. PubMed ID: 15229100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic inflammation in patients with COPD and pulmonary hypertension.
    Joppa P; Petrasova D; Stancak B; Tkacova R
    Chest; 2006 Aug; 130(2):326-33. PubMed ID: 16899829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
    Saldías PF; Díaz PO; Dreyse DJ; Gaggero BA; Sandoval AC; Lisboa BC
    Rev Med Chil; 2012 Jan; 140(1):10-8. PubMed ID: 22552550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers.
    Krommidas G; Kostikas K; Papatheodorou G; Koutsokera A; Gourgoulianis KI; Roussos C; Koulouris NG; Loukides S
    Respir Med; 2010 Jan; 104(1):40-6. PubMed ID: 19782551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
    Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
    Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower leptin/adiponectin ratio and risk of rapid lung function decline in chronic obstructive pulmonary disease.
    Suzuki M; Makita H; Östling J; Thomsen LH; Konno S; Nagai K; Shimizu K; Pedersen JH; Ashraf H; Bruijnzeel PL; Maciewicz RA; Nishimura M; ;
    Ann Am Thorac Soc; 2014 Dec; 11(10):1511-9. PubMed ID: 25372271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein levels, haplotypes, and the risk of incident chronic obstructive pulmonary disease.
    van Durme YM; Verhamme KM; Aarnoudse AJ; Van Pottelberge GR; Hofman A; Witteman JC; Joos GF; Brusselle GG; Stricker BH
    Am J Respir Crit Care Med; 2009 Mar; 179(5):375-82. PubMed ID: 19096002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A longitudinal study evaluating the effect of exacerbations on physical activity in patients with chronic obstructive pulmonary disease.
    Ehsan M; Khan R; Wakefield D; Qureshi A; Murray L; Zuwallack R; Leidy NK
    Ann Am Thorac Soc; 2013 Dec; 10(6):559-64. PubMed ID: 24053416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD.
    Tkacova R; Kluchova Z; Joppa P; Petrasova D; Molcanyiova A
    Respir Med; 2007 Aug; 101(8):1670-6. PubMed ID: 17449234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia.
    Duman D; Aksoy E; Agca MC; Kocak ND; Ozmen I; Akturk UA; Gungor S; Tepetam FM; Eroglu SA; Oztas S; Karakurt Z
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2469-78. PubMed ID: 26648709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.